dasatinib
Showing 1 - 25 of 196
Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)
Recruiting
- Waldenstrom Macroglobulinemia
- DASATINIB
- Dasatinib
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 22, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
- Dasatinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 24, 2022
Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)
Completed
- Solid Tumors
- Bevacizumab
- Dasatinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Prostate Cancer Trial (Dasatinib)
Withdrawn
- Prostate Cancer
- Dasatinib
- (no location specified)
Feb 23, 2022
Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- +3 more
- Dasatinib
- Decitabine and Cedazuridine
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Dasatinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 25, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Dasatinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 15, 2021
Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)
Recruiting
- Chronic Myeloid Leukemia in Chronic Phase
- Flumatinib
- Dasatinib
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Jul 26, 2022
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)
Completed
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
- dasatinib
-
Valencia, SpainHospital La Fe
Mar 16, 2022
Multiple Indications Cancer Trial in France, Poland (Dasatinib)
Active, not recruiting
- Multiple Indications Cancer
- Dasatinib
-
Besancon, France
- +5 more
Dec 2, 2021
Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)
Terminated
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Dasatinib
- +2 more
-
Chicago, Illinois
- +1 more
Jun 2, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
- Dasatinib
- Ganitumab
-
Los Angeles, California
- +1 more
Mar 17, 2022
Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)
Completed
- Breast Cancer
- Bone Metastases
- Dasatinib
- Zoledronic Acid
-
Chicago, Illinois
- +2 more
Feb 2, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Oct 12, 2021
EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)
Active, not recruiting
- EGFR Gene Mutation
- Nonsmall Cell Lung Cancer
- Dasatinib
- Osimertinib
-
Washington, District of Columbia
- +1 more
Jan 9, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Dasatinib
-
Amman, Jordan
- +4 more
Jan 17, 2022
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- Dasatinib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 15, 2021
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +8 more
- cytarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Mild Cognitive Impairment, Alzheimer Trial in Rochester (Dasatinib, Quercetin)
Enrolling by invitation
- Mild Cognitive Impairment
- Alzheimer Disease
- Dasatinib
- Quercetin
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 2, 2022
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 4, 2022
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- Dasatinib
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021
Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)
Completed
- Pancreatic Cancer Metastatic
- Dasatinib
- mFOLFOX6
-
Gainesville, FloridaUF Health Cancer Center
Dec 3, 2020